JMP Securities Downgrades Trillium Therapeutics (TRIL) to Market Perform
Tweet Send to a Friend
JMP Securities analyst Reni Benjamin downgraded Trillium Therapeutics (NASDAQ: TRIL) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
